ЗНАЧЕНИЕ ГИПЕРГОМОЦИСТЕИНЕМИИ В РАЗВИТИИ ЗАБОЛЕВАНИЙ АРТЕРИАЛЬНЫХ СОСУДОВ И СЕРДЦА
Аннотация
В данной работе проведен анализ литературных научных источников и данных MEDLINE, касающихся проблемы гипергомоцистеинемии, как дополнительного модифицируемого фактора риска сердечно-сосудистых заболеваний.
Литература
I. Костюченко, Г.И. Гипергомоцистеинемия и коронарная болезнь сердца как проблема пожилого возраста / Г.И. Костюченко, З.С. Баркаган // Клин. геронтол. - 2003. - № 5. - C. 9 - 12.
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians / M. Stampfer [et al.] // JAMA.
- 1992. - Vol. 268. - P. 877 - 881.
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease / C. Boushey [et al.] // JAMA. - 1995. - Vol. 274. - P. 1049 - 1057.
Association between elevated plasma total homocysteine and increased common carotid artery wall thickness / S. Voutilainen [et al.] // Ann. Med. - 1998. - Vol. 30. - P. 300 - 306.
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis / J. Selhub [et al.] // N. Engl. J. Med. - 1995. - Vol. 332. - P. 286 - 291.
Augmented effects of methionine and cholesterol in decreasing the elastic lamina while thickening the aortic wall in the rat aorta / A. Zulli [et al.] // Clin. Sci. (Colch.). - 1998. - Vol. 95, № 5. - P. 589 - 593.
Brattstrцm, L. Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease / L. Brattst^m // Circulation. - 1997. - Vol. 96. - P. 3805 - 3806.
Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis in Communities (ARIC) Study / M. R. Malinow [et al.] // Circulation. - 1993. - Vol.87. - P. 1107 - 1113.
Correlation between plasma homocyst(e)ine and aortic atherosclerosis / N. Konechy [et al.] // Am. Heart. - 1997. - Vol. 133.
- P. 534 - 540.
Cystathionine B-synthase mutations in homocystinuria / J.P. Kraus [et al.] // Hum. Mutat. - 1999. - № 13. - P. 362 - 375.
II. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels / G. Schnyder [et al.] // N. Engl. J. Med. - 2001.
- Vol. 345. - P. 1593 -1600.
Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models / C. Chen [et al.] // J. Surg. Rex. - 2000. - Vol. 881. - P. 26 - 33.
Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients / C.J Glueck. [et al.] // Am. J. Cardiol. - 1995. - Vol. 75. - P. 132 - 136.
Folate acid, vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women / E. Rimm [et al.] // JAMA. - 1998. - Vol. 279. - P. 359 - 364.
Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease / G. Boers [et al.] // N. Engl. J. Med. - 1985. - Vol. 313. - P. 709 -715.
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis / D.S. Wald [et al.] // BMJ. - 2002. - Vol. 325. - P. 1202-1206.
Homocysteine and ischemic heart disease / N. Wald [et al.] / / Arch. Intern. Med. - 1998. - Vol. 1158. - P. 862 - 867.
Homocysteine level and coronary artery disease / M. B. Kazemi [et al.] // Angiology. - 2006. - Vol. 57, № 1. - P. 9 - 14.
Homocysteine stimulates the production and secretion of cholesterol in hepatic cells / E.G. Lynn [et al.] // Biochim. Biophys. Act. - 1998. - Vol. l393, № 2/3. - P. 317 - 324.
Hyperhomocyst(e)inemia: an independent risk factor for claudication / J. Molgaard [et al.] // J. Intern. Med. - 1992. - Vol. 231.
- P. 273 - 279.
Hyperhomocysteinemia after an oral methionme load acutely impairs endothelial function in healthy adults / M.F. Bellamy [et al.] // Circulation. - 1998. - Vol. 98, - № 18. - P.1848 - 1852.
Hyperhomocystinemia in patients with coronary artery disease / J. R. Faria-Neto [et al.] // Braz. J. Med. Biol. Res. - 2006. - Vol. 39, № 4. - P. 455 - 463.
Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease / K. Robinson [et al.] // Circulation. - 1998. - Vol. 97. - P. 437 - 443.
McCully, K. The Homocysteine Revolution / K. McCully. - New Canaan: Keats Publishing Inc, - 1997. - 510 p.
Plasma homocysteine and severity of atherosclerosis in young adults with lower limb atherosclerotic disease / M.L. Van der Berg [et al.] // Arterioscler. Thromb. Vasc. Biol. - 1996. - № 16. - P. 165 - 175.
Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project / I. Graham [et al.] // JAMA.
- 1997. - Vol. 277. - P. 1775 - 1781.
Plasma homocysteine levels and mortality in patients with coronary artery disease / O. Nygard [et al.] // N. Engl. J. Med. - 1997.
- Vol. 1337. - P. 230 - 236.
Plasma total homocysteine levels in patients with early- onset coronary heart disease and low cardiovascular risk profile / M. G. Donner [et al.] // Metabolism. - 1998. - Vol. 47. - P. 273 - 279.
Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis / P. Verhoef [et al.] // Arterioscler. Thromb. Vasc. Biol. - 1997. - № 17. - P. 989 - 995.
0. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease / M. Malinow [et al.] // Circulation.
- 1989. - Vol.79. - P. 1180 -1188.
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis Risk in Communities (ARIC) Study / A. R. Folsom [et al.] // Circulation. - 1998. - Vol. 98. - P. 204
- 210.
Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study / G. Alfthan [et al.] // Atherosclerosis. - 1994. - Vol. 106. - P. 9 -19.
Restenosis in Intervened Coronaries with Hyperhomocysteinemia (RICH) / S.A. Kojoglanian [et al.] // Am. Heart. J. - 2003. - Vol. 146, № 6. - P. 1077 - 1081.
Scriver, C. R. The Metabolic and Molecular Basis of lnherited Disease / C. R. Scriver [et al.] - New York: McGraw-Hill, - 1995. - P. 1279 - 1327.
The MRFIT Research Group. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial / R. Evans [et al.] // Thromb. Vasc. Biol. - 1997. - № 17. - P. 1947 - 1953.
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease / L. A. J. Kluijtmans [et al.] // Circulation. - 1997. - Vol. 96. - P. 2573 - 2577.
Van Beynum, I.M. Hyperhomocysteinemia; a risk factor for stroke in children / I.M. Van Beynum // Circulation. - 1999. - Vol. 99.
- P. 2070 - 2072.
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population / J. Selhub [et al.] // JAMA.
- 1993. - Vol. 270. - P. 2693 - 2698.
Wilcken, D. The pathogenesis of coronary artery disease. A possible role for methionine metabolism / D. Wilcken, B. Wilcken / / J. Clin. Invest. - 1976. - Vol. 57. - P. 1079 - 1082.
